Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kawasaki disease and immunisation: A systematic review.
Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Felicetti P, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Trotta F, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group. Phuong LK, et al. Among authors: goldenthal kl. Vaccine. 2017 Mar 27;35(14):1770-1779. doi: 10.1016/j.vaccine.2016.09.033. Epub 2017 Mar 2. Vaccine. 2017. PMID: 28259442 Review.
Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.
Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D; Brighton Collaboration Kawasaki Disease (KD) Working Group. Phuong LK, et al. Among authors: goldenthal kl. Vaccine. 2016 Dec 12;34(51):6582-6596. doi: 10.1016/j.vaccine.2016.09.025. Epub 2016 Nov 15. Vaccine. 2016. PMID: 27863715 Review. No abstract available.
Template protocol for clinical trials investigating vaccines--focus on safety elements.
Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker KB, Wilson P, Wong V, Zaman K, Heininger U; Brighton Collaboration Clinical Trial Protocol Working Group. Bonhoeffer J, et al. Among authors: goldenthal kl. Vaccine. 2013 Nov 12;31(47):5602-20. doi: 10.1016/j.vaccine.2013.02.041. Epub 2013 Mar 13. Vaccine. 2013. PMID: 23499603 Free PMC article.
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.
Baxter R, Patriarca PA, Ensor K, Izikson R, Goldenthal KL, Cox MM. Baxter R, et al. Among authors: goldenthal kl. Vaccine. 2011 Mar 9;29(12):2272-8. doi: 10.1016/j.vaccine.2011.01.039. Epub 2011 Jan 28. Vaccine. 2011. PMID: 21277410 Clinical Trial.
Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.
Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, Goldenthal KL, Kohberger R, Dunkle LM. Treanor JJ, et al. Among authors: goldenthal kl. Vaccine. 2013 Nov 19;31(48):5760-5. doi: 10.1016/j.vaccine.2013.08.064. Epub 2013 Sep 27. Vaccine. 2013. PMID: 24075920 Clinical Trial.
34 results